Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$251K Sell
2,090
-936
-31% -$125K 0.01% 478
2025
Q1
$446K Sell
3,026
-1,243
-29% -$190K 0.03% 326
2024
Q4
$693K Buy
4,269
+370
+9% +$60.5K 0.04% 245
2024
Q3
$635K Buy
3,899
+854
+28% +$127K 0.04% 251
2024
Q2
$416K Sell
3,045
-209
-6% -$29K 0.03% 319
2024
Q1
$498K Buy
3,254
+1,795
+123% +$268K 0.04% 283
2023
Q4
$208K Buy
+1,459
New +$195K 0.02% 418

Other funds holding CLX

Graypoint LLC's CLX Position: Q2 2025 in Review

Graypoint LLC reduced its Clorox (CLX) stake by 31% in Q2 2025, selling an estimated $125K and leaving 2,090 shares worth $251K. The position accounts for 0.01% of the portfolio, ranked #478.

Graypoint LLC first reported a position in CLX in Q4 2023 and has held it in 7 quarters since. The position peaked at $693K in Q4 2024. 1,125 funds tracked by Wall St. Rank hold CLX as of Q2 2025.

  • Graypoint LLC held 2,090 shares of Clorox worth $251K as of Q2 2025.
  • Graypoint LLC sold 936 Clorox shares in Q2 2025, an estimated $125K.
  • Clorox made up 0.01% of Graypoint LLC's portfolio in Q2 2025, its #478 holding.
  • Graypoint LLC first reported a position in Clorox in Q4 2023 and has held it in 7 quarters since.
  • Graypoint LLC's Clorox position peaked at $693K in Q4 2024.
  • 1,125 funds tracked by Wall St. Rank held Clorox as of Q2 2025.

Based on Graypoint LLC's 13F filing for Q2 2025, filed 15 Jul 2025.